Investigation of the Adequacy of 100 IU/Kg Unfractionated Heparin Loading Dose by Activated Clotting Time In Children With Congenital Heart Disease During Cardiac Catheterization

Purpose: This study investigated whether an activated clotting time (ACT) between 200 and 300 sec could be achieved with a100 IU/kg unfractionated heparin (UHF) loading dose in patients with congenital heart disease (CHD) during pediatric cardiac catheterization. Materials and Methods: We included 2...

Full description

Saved in:
Bibliographic Details
Main Authors: Nimet Cındık, Mahmut Gokdemır
Format: Article
Language:English
Published: Selcuk University Press 2023-10-01
Series:Genel Tıp Dergisi
Subjects:
Online Access:https://dergipark.org.tr/tr/download/article-file/3278472
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841562235477950464
author Nimet Cındık
Mahmut Gokdemır
author_facet Nimet Cındık
Mahmut Gokdemır
author_sort Nimet Cındık
collection DOAJ
description Purpose: This study investigated whether an activated clotting time (ACT) between 200 and 300 sec could be achieved with a100 IU/kg unfractionated heparin (UHF) loading dose in patients with congenital heart disease (CHD) during pediatric cardiac catheterization. Materials and Methods: We included 264 patients aged 0-18 years with CHD undergoing cardiac catheterization between January 2022-March 2023. Data on patient characteristics, UHF doses, and ACT values were retrospectively obtained. The patients were intravenously administered 100 IU/kg UFH after sheath placement. We aimed to obtain a value between 200 and 300 sec according to the ACT measured at the 5th minute. If the measured ACT value at the 5th min was < 200 sec, additional heparin doses between 20 and 50 IU/kg were administered such that the total heparin loading dose did not exceed 150 IU/kg. Patients were divided into two groups based on whether the ACT value was below or above 200 sec. Results: Median age, weight, and ACT value at procedure were 6.41(IQR:2.01–32.21) months, 6.13(IQR:3.79-11.9) kg, and 212(IQR:190-240) sec, respectively. The ACT value of 170(64.4%) of the 264 patients was between 200-300 sec, which was considered the target value. The ACT value of 86(32.6%) of the 264 patients was below the target value and that of eight (3%) patients was above the target value. Hematoma occurred at the access site in four patients (1.5%). We did not detect retroperitoneal hematoma, other bleedings at location, or thromboembolism in any of the patients. No significant differences were observed in comparisons between age subgroups and ACT distribution, or between age subgroups and ACT subgroups (p>0.05) Conclusion: This study revealed that a 100 IU/kg UFH loading dose produced the target ACT value in 64.4% of the patients and that the UFH loading dose should be individualized according to the ACT value in the remaining patients.
format Article
id doaj-art-443c8f367d2745cfaea659ab3b883197
institution Kabale University
issn 2602-3741
language English
publishDate 2023-10-01
publisher Selcuk University Press
record_format Article
series Genel Tıp Dergisi
spelling doaj-art-443c8f367d2745cfaea659ab3b8831972025-01-03T01:05:22ZengSelcuk University PressGenel Tıp Dergisi2602-37412023-10-0133558859310.54005/geneltip.1330759154Investigation of the Adequacy of 100 IU/Kg Unfractionated Heparin Loading Dose by Activated Clotting Time In Children With Congenital Heart Disease During Cardiac CatheterizationNimet Cındık0Mahmut Gokdemır1BAŞKENT ÜNİVERSİTESİBAŞKENT ÜNİVERSİTESİPurpose: This study investigated whether an activated clotting time (ACT) between 200 and 300 sec could be achieved with a100 IU/kg unfractionated heparin (UHF) loading dose in patients with congenital heart disease (CHD) during pediatric cardiac catheterization. Materials and Methods: We included 264 patients aged 0-18 years with CHD undergoing cardiac catheterization between January 2022-March 2023. Data on patient characteristics, UHF doses, and ACT values were retrospectively obtained. The patients were intravenously administered 100 IU/kg UFH after sheath placement. We aimed to obtain a value between 200 and 300 sec according to the ACT measured at the 5th minute. If the measured ACT value at the 5th min was < 200 sec, additional heparin doses between 20 and 50 IU/kg were administered such that the total heparin loading dose did not exceed 150 IU/kg. Patients were divided into two groups based on whether the ACT value was below or above 200 sec. Results: Median age, weight, and ACT value at procedure were 6.41(IQR:2.01–32.21) months, 6.13(IQR:3.79-11.9) kg, and 212(IQR:190-240) sec, respectively. The ACT value of 170(64.4%) of the 264 patients was between 200-300 sec, which was considered the target value. The ACT value of 86(32.6%) of the 264 patients was below the target value and that of eight (3%) patients was above the target value. Hematoma occurred at the access site in four patients (1.5%). We did not detect retroperitoneal hematoma, other bleedings at location, or thromboembolism in any of the patients. No significant differences were observed in comparisons between age subgroups and ACT distribution, or between age subgroups and ACT subgroups (p>0.05) Conclusion: This study revealed that a 100 IU/kg UFH loading dose produced the target ACT value in 64.4% of the patients and that the UFH loading dose should be individualized according to the ACT value in the remaining patients.https://dergipark.org.tr/tr/download/article-file/3278472konjenital kalp hastalığıkalp kateterizasyonufraksiyone olmayan heparinaktif pıhtılaşma zamanıcongenital heart diseasecardiac catheterizationunfractionated heparinactivated clotting time
spellingShingle Nimet Cındık
Mahmut Gokdemır
Investigation of the Adequacy of 100 IU/Kg Unfractionated Heparin Loading Dose by Activated Clotting Time In Children With Congenital Heart Disease During Cardiac Catheterization
Genel Tıp Dergisi
konjenital kalp hastalığı
kalp kateterizasyonu
fraksiyone olmayan heparin
aktif pıhtılaşma zamanı
congenital heart disease
cardiac catheterization
unfractionated heparin
activated clotting time
title Investigation of the Adequacy of 100 IU/Kg Unfractionated Heparin Loading Dose by Activated Clotting Time In Children With Congenital Heart Disease During Cardiac Catheterization
title_full Investigation of the Adequacy of 100 IU/Kg Unfractionated Heparin Loading Dose by Activated Clotting Time In Children With Congenital Heart Disease During Cardiac Catheterization
title_fullStr Investigation of the Adequacy of 100 IU/Kg Unfractionated Heparin Loading Dose by Activated Clotting Time In Children With Congenital Heart Disease During Cardiac Catheterization
title_full_unstemmed Investigation of the Adequacy of 100 IU/Kg Unfractionated Heparin Loading Dose by Activated Clotting Time In Children With Congenital Heart Disease During Cardiac Catheterization
title_short Investigation of the Adequacy of 100 IU/Kg Unfractionated Heparin Loading Dose by Activated Clotting Time In Children With Congenital Heart Disease During Cardiac Catheterization
title_sort investigation of the adequacy of 100 iu kg unfractionated heparin loading dose by activated clotting time in children with congenital heart disease during cardiac catheterization
topic konjenital kalp hastalığı
kalp kateterizasyonu
fraksiyone olmayan heparin
aktif pıhtılaşma zamanı
congenital heart disease
cardiac catheterization
unfractionated heparin
activated clotting time
url https://dergipark.org.tr/tr/download/article-file/3278472
work_keys_str_mv AT nimetcındık investigationoftheadequacyof100iukgunfractionatedheparinloadingdosebyactivatedclottingtimeinchildrenwithcongenitalheartdiseaseduringcardiaccatheterization
AT mahmutgokdemır investigationoftheadequacyof100iukgunfractionatedheparinloadingdosebyactivatedclottingtimeinchildrenwithcongenitalheartdiseaseduringcardiaccatheterization